LymphedemaV1, PubMed, Corpus, bibRecord, 001E29

Neoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva.

Identifieur interne : 001E29 ( PubMed/Corpus ); précédent : 001E28; suivant : 001E30

Neoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva.

Auteurs : A. Gaudineau ; D. Weitbruch ; P. Quetin ; S. Heymann ; T. Petit ; P. Volkmar ; F. Bodin ; M. Velten ; J F Rodier

Source :

Oncology letters [ 1792-1074 ] ; 2012.

RBID : pubmed:23205089

Abstract

Alternative therapies have been sought to alleviate mutilation and morbidity associated with surgery for vulvar neoplasms. Our prime objective was to assess tumor absence in pathological vulvar and nodal specimens following neoadjuvant chemoradiotherapy in locally advanced vulvar neoplasms. Data were retrospectively collected from January 2001 to May 2009 from 22 patients treated with neoadjuvant therapy for locally advanced squamous cell carcinoma of the vulva. Neoadjuvant treatment consisted of inguino-pelvic radiotherapy (50 Gy) in association with chemotherapy when possible. Surgery occurred at intervals of between 5 to 8 weeks. The median age of patients at diagnosis was 74.1 years. All patients were primarily treated with radiotherapy and 15 received a concomitant chemotherapy. Additionally, all patients underwent radical vulvectomy and bilateral inguino-femoral lymphadenectomy. Tumor absence in the vulvar and nodal pathological specimens was achieved for 6 (27%) patients, while absence in the vulvar pathological specimens was only achieved for 10 (45.4%) patients. Postoperative follow-up revealed breakdown of groin wounds, vulvar wounds and chronic lymphedema in 3 (14.3%), 7 (31.8%) and 14 cases (63.6%), respectively. Within a median follow-up time of 2.3 years [interquartile range (IQR), 0.6-4.6], 12 (54.6%) patients experienced complete remission and 6 cases succumbed to metastatic evolution within a median of 2.2 years (IQR, 0.6-4.6), with 1 case also experiencing perineal recurrence. Median survival time, estimated using the Kaplan-Meier method, was 5.1 years (IQR, 1.0-6.8). We suggest that neoadjuvant chemoradiotherapy may represent a reliable and promising strategy in locally advanced squamous cell carcinoma of the vulva.

DOI: 10.3892/ol.2012.831
PubMed: 23205089

Links to Exploration step

pubmed:23205089

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Neoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva.</title>
<author><name sortKey="Gaudineau, A" sort="Gaudineau, A" uniqKey="Gaudineau A" first="A" last="Gaudineau">A. Gaudineau</name>
<affiliation><nlm:affiliation>Departments of Surgical Oncology and.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Weitbruch, D" sort="Weitbruch, D" uniqKey="Weitbruch D" first="D" last="Weitbruch">D. Weitbruch</name>
</author>
<author><name sortKey="Quetin, P" sort="Quetin, P" uniqKey="Quetin P" first="P" last="Quetin">P. Quetin</name>
</author>
<author><name sortKey="Heymann, S" sort="Heymann, S" uniqKey="Heymann S" first="S" last="Heymann">S. Heymann</name>
</author>
<author><name sortKey="Petit, T" sort="Petit, T" uniqKey="Petit T" first="T" last="Petit">T. Petit</name>
</author>
<author><name sortKey="Volkmar, P" sort="Volkmar, P" uniqKey="Volkmar P" first="P" last="Volkmar">P. Volkmar</name>
</author>
<author><name sortKey="Bodin, F" sort="Bodin, F" uniqKey="Bodin F" first="F" last="Bodin">F. Bodin</name>
</author>
<author><name sortKey="Velten, M" sort="Velten, M" uniqKey="Velten M" first="M" last="Velten">M. Velten</name>
</author>
<author><name sortKey="Rodier, J F" sort="Rodier, J F" uniqKey="Rodier J" first="J F" last="Rodier">J F Rodier</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:23205089</idno>
<idno type="pmid">23205089</idno>
<idno type="doi">10.3892/ol.2012.831</idno>
<idno type="wicri:Area/PubMed/Corpus">001E29</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E29</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Neoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva.</title>
<author><name sortKey="Gaudineau, A" sort="Gaudineau, A" uniqKey="Gaudineau A" first="A" last="Gaudineau">A. Gaudineau</name>
<affiliation><nlm:affiliation>Departments of Surgical Oncology and.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Weitbruch, D" sort="Weitbruch, D" uniqKey="Weitbruch D" first="D" last="Weitbruch">D. Weitbruch</name>
</author>
<author><name sortKey="Quetin, P" sort="Quetin, P" uniqKey="Quetin P" first="P" last="Quetin">P. Quetin</name>
</author>
<author><name sortKey="Heymann, S" sort="Heymann, S" uniqKey="Heymann S" first="S" last="Heymann">S. Heymann</name>
</author>
<author><name sortKey="Petit, T" sort="Petit, T" uniqKey="Petit T" first="T" last="Petit">T. Petit</name>
</author>
<author><name sortKey="Volkmar, P" sort="Volkmar, P" uniqKey="Volkmar P" first="P" last="Volkmar">P. Volkmar</name>
</author>
<author><name sortKey="Bodin, F" sort="Bodin, F" uniqKey="Bodin F" first="F" last="Bodin">F. Bodin</name>
</author>
<author><name sortKey="Velten, M" sort="Velten, M" uniqKey="Velten M" first="M" last="Velten">M. Velten</name>
</author>
<author><name sortKey="Rodier, J F" sort="Rodier, J F" uniqKey="Rodier J" first="J F" last="Rodier">J F Rodier</name>
</author>
</analytic>
<series><title level="j">Oncology letters</title>
<idno type="ISSN">1792-1074</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Alternative therapies have been sought to alleviate mutilation and morbidity associated with surgery for vulvar neoplasms. Our prime objective was to assess tumor absence in pathological vulvar and nodal specimens following neoadjuvant chemoradiotherapy in locally advanced vulvar neoplasms. Data were retrospectively collected from January 2001 to May 2009 from 22 patients treated with neoadjuvant therapy for locally advanced squamous cell carcinoma of the vulva. Neoadjuvant treatment consisted of inguino-pelvic radiotherapy (50 Gy) in association with chemotherapy when possible. Surgery occurred at intervals of between 5 to 8 weeks. The median age of patients at diagnosis was 74.1 years. All patients were primarily treated with radiotherapy and 15 received a concomitant chemotherapy. Additionally, all patients underwent radical vulvectomy and bilateral inguino-femoral lymphadenectomy. Tumor absence in the vulvar and nodal pathological specimens was achieved for 6 (27%) patients, while absence in the vulvar pathological specimens was only achieved for 10 (45.4%) patients. Postoperative follow-up revealed breakdown of groin wounds, vulvar wounds and chronic lymphedema in 3 (14.3%), 7 (31.8%) and 14 cases (63.6%), respectively. Within a median follow-up time of 2.3 years [interquartile range (IQR), 0.6-4.6], 12 (54.6%) patients experienced complete remission and 6 cases succumbed to metastatic evolution within a median of 2.2 years (IQR, 0.6-4.6), with 1 case also experiencing perineal recurrence. Median survival time, estimated using the Kaplan-Meier method, was 5.1 years (IQR, 1.0-6.8). We suggest that neoadjuvant chemoradiotherapy may represent a reliable and promising strategy in locally advanced squamous cell carcinoma of the vulva.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">23205089</PMID>
<DateCreated><Year>2012</Year>
<Month>12</Month>
<Day>03</Day>
</DateCreated>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1792-1074</ISSN>
<JournalIssue CitedMedium="Print"><Volume>4</Volume>
<Issue>4</Issue>
<PubDate><Year>2012</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Oncology letters</Title>
<ISOAbbreviation>Oncol Lett</ISOAbbreviation>
</Journal>
<ArticleTitle>Neoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva.</ArticleTitle>
<Pagination><MedlinePgn>719-722</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Alternative therapies have been sought to alleviate mutilation and morbidity associated with surgery for vulvar neoplasms. Our prime objective was to assess tumor absence in pathological vulvar and nodal specimens following neoadjuvant chemoradiotherapy in locally advanced vulvar neoplasms. Data were retrospectively collected from January 2001 to May 2009 from 22 patients treated with neoadjuvant therapy for locally advanced squamous cell carcinoma of the vulva. Neoadjuvant treatment consisted of inguino-pelvic radiotherapy (50 Gy) in association with chemotherapy when possible. Surgery occurred at intervals of between 5 to 8 weeks. The median age of patients at diagnosis was 74.1 years. All patients were primarily treated with radiotherapy and 15 received a concomitant chemotherapy. Additionally, all patients underwent radical vulvectomy and bilateral inguino-femoral lymphadenectomy. Tumor absence in the vulvar and nodal pathological specimens was achieved for 6 (27%) patients, while absence in the vulvar pathological specimens was only achieved for 10 (45.4%) patients. Postoperative follow-up revealed breakdown of groin wounds, vulvar wounds and chronic lymphedema in 3 (14.3%), 7 (31.8%) and 14 cases (63.6%), respectively. Within a median follow-up time of 2.3 years [interquartile range (IQR), 0.6-4.6], 12 (54.6%) patients experienced complete remission and 6 cases succumbed to metastatic evolution within a median of 2.2 years (IQR, 0.6-4.6), with 1 case also experiencing perineal recurrence. Median survival time, estimated using the Kaplan-Meier method, was 5.1 years (IQR, 1.0-6.8). We suggest that neoadjuvant chemoradiotherapy may represent a reliable and promising strategy in locally advanced squamous cell carcinoma of the vulva.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gaudineau</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Departments of Surgical Oncology and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Weitbruch</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Quetin</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Heymann</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Petit</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Volkmar</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bodin</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Velten</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rodier</LastName>
<ForeName>J F</ForeName>
<Initials>JF</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2012</Year>
<Month>07</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Greece</Country>
<MedlineTA>Oncol Lett</MedlineTA>
<NlmUniqueID>101531236</NlmUniqueID>
<ISSNLinking>1792-1074</ISSNLinking>
</MedlineJournalInfo>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2000 Jul 15;47(5):1235-44</RefSource>
<PMID Version="1">10889377</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Plast Surg. 1997 Jun;38(6):563-76; discussion 577</RefSource>
<PMID Version="1">9188971</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 1993;32(6):657-61</RefSource>
<PMID Version="1">7505091</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Crit Rev Oncol Hematol. 2012 Apr;82(1):25-39</RefSource>
<PMID Version="1">21601474</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2000 Sep 1;48(2):415-20</RefSource>
<PMID Version="1">10974455</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1995 May 1;75(9):2289-94</RefSource>
<PMID Version="1">7712439</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Obstet Gynecol Scand. 1982;61(3):195-7</RefSource>
<PMID Version="1">6181648</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 2004 Jun;93(3):659-66</RefSource>
<PMID Version="1">15196861</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1996 Apr 15;77(8):1472-8</RefSource>
<PMID Version="1">8608531</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 2005 Dec;99(3):640-4</RefSource>
<PMID Version="1">16169579</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1007-13</RefSource>
<PMID Version="1">11072157</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Gynecol Cancer. 2009 May;19(4):745-51</RefSource>
<PMID Version="1">19509582</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 1996 Jun;61(3):321-7</RefSource>
<PMID Version="1">8641609</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 1995 Oct;59(1):51-6</RefSource>
<PMID Version="1">7557615</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 1986 Sep;25(1):20-5</RefSource>
<PMID Version="1">3732915</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 1991 Jul;42(1):9-21</RefSource>
<PMID Version="1">1916517</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):79-85</RefSource>
<PMID Version="1">9747823</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 1997 Aug;66(2):258-61</RefSource>
<PMID Version="1">9264573</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1988 Oct;15(4):901-6</RefSource>
<PMID Version="1">3141319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 1991 Sep;42(3):197-201</RefSource>
<PMID Version="1">1955180</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Clin Oncol. 1987 Apr;10(2):171-81</RefSource>
<PMID Version="1">3565317</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gynecol Oncol. 1992 Oct;47(1):14-20</RefSource>
<PMID Version="1">1427394</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1993 Aug 1;26(5):809-16</RefSource>
<PMID Version="1">8344850</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1984 Nov 15;54(10):2056-61</RefSource>
<PMID Version="1">6488136</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year>
<Month>03</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2012</Year>
<Month>06</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>12</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>12</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2012</Year>
<Month>12</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">23205089</ArticleId>
<ArticleId IdType="doi">10.3892/ol.2012.831</ArticleId>
<ArticleId IdType="pii">ol-04-04-0719</ArticleId>
<ArticleId IdType="pmc">PMC3506666</ArticleId>
</ArticleIdList>
<pmc-dir>pmcsd</pmc-dir>
    </PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E29 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001E29 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:23205089
   |texte=   Neoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:23205089" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Neoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva.

Neoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva.

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki